Europe Peptic Ulcer Drugs Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Peptic Ulcer Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Peptic Ulcer Drugs Market Segmentations:

    By Player:

    • AstraZeneca plc

    • Takeda Pharmaceutical Co. Ltd.

    • Dr Reddy's Laboratories

    • Pfizer

    • Pozen

    • Daiichi Sankyo

    • Takeda Pharmaceutical Co Ltd

    • Taiho Pharmaceutical

    • Eumedica

    • Eisai Co Ltd

    • Ferring Pharmaceuticals

    • Daewoong Pharmaceutical Co Ltd

    • Dr. Reddy's Laboratories

    • PharmaKing

    • Johnson and Johnson

    • Otsuka Holdings

    • Eisai Co. Ltd.

    • Horizon Pharma

    • Daewoong Pharmaceutical Co. Ltd.

    By Type:

    • Proton Pump Inhibitors (PPIs)

    • Potassium-Competitive Acid Blockers

    • Antacids

    • H2-antagonists

    • Antibiotics

    • Ulcer Protective Drugs

    By End-User:

    • Hospital Pharmacies

    • Private Clinics

    • Drug Stores

    • Retail Pharmacies

    • E-Commerce

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptic Ulcer Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Peptic Ulcer Drugs Market Size and Growth Rate of Proton Pump Inhibitors (PPIs) from 2014 to 2026

    • 1.3.2 Europe Peptic Ulcer Drugs Market Size and Growth Rate of Potassium-Competitive Acid Blockers from 2014 to 2026

    • 1.3.3 Europe Peptic Ulcer Drugs Market Size and Growth Rate of Antacids from 2014 to 2026

    • 1.3.4 Europe Peptic Ulcer Drugs Market Size and Growth Rate of H2-antagonists from 2014 to 2026

    • 1.3.5 Europe Peptic Ulcer Drugs Market Size and Growth Rate of Antibiotics from 2014 to 2026

    • 1.3.6 Europe Peptic Ulcer Drugs Market Size and Growth Rate of Ulcer Protective Drugs from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Peptic Ulcer Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • 1.4.2 Europe Peptic Ulcer Drugs Market Size and Growth Rate of Private Clinics from 2014 to 2026

    • 1.4.3 Europe Peptic Ulcer Drugs Market Size and Growth Rate of Drug Stores from 2014 to 2026

    • 1.4.4 Europe Peptic Ulcer Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.4.5 Europe Peptic Ulcer Drugs Market Size and Growth Rate of E-Commerce from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Peptic Ulcer Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Peptic Ulcer Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Proton Pump Inhibitors (PPIs)

      • 3.4.2 Market Size and Growth Rate of Potassium-Competitive Acid Blockers

      • 3.4.3 Market Size and Growth Rate of Antacids

      • 3.4.4 Market Size and Growth Rate of H2-antagonists

      • 3.4.5 Market Size and Growth Rate of Antibiotics

      • 3.4.6 Market Size and Growth Rate of Ulcer Protective Drugs

    4 Segmentation of Peptic Ulcer Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Peptic Ulcer Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Peptic Ulcer Drugs for Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Peptic Ulcer Drugs for Private Clinics

      • 4.4.3 Market Size and Growth Rate of Peptic Ulcer Drugs for Drug Stores

      • 4.4.4 Market Size and Growth Rate of Peptic Ulcer Drugs for Retail Pharmacies

      • 4.4.5 Market Size and Growth Rate of Peptic Ulcer Drugs for E-Commerce

    5 Market Analysis by Major Regions

    • 5.1 Europe Peptic Ulcer Drugs Production Analysis by Top Regions

    • 5.2 Europe Peptic Ulcer Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Peptic Ulcer Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Peptic Ulcer Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Peptic Ulcer Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Peptic Ulcer Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Peptic Ulcer Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Peptic Ulcer Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Peptic Ulcer Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Peptic Ulcer Drugs Landscape Analysis

    • 7.1 Germany Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 7.2 Germany Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    8. UK Peptic Ulcer Drugs Landscape Analysis

    • 8.1 UK Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 8.2 UK Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    9. France Peptic Ulcer Drugs Landscape Analysis

    • 9.1 France Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 9.2 France Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    10. Italy Peptic Ulcer Drugs Landscape Analysis

    • 10.1 Italy Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 10.2 Italy Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    11. Spain Peptic Ulcer Drugs Landscape Analysis

    • 11.1 Spain Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 11.2 Spain Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    12. Poland Peptic Ulcer Drugs Landscape Analysis

    • 12.1 Poland Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 12.2 Poland Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    13. Russia Peptic Ulcer Drugs Landscape Analysis

    • 13.1 Russia Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 13.2 Russia Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    14. Switzerland Peptic Ulcer Drugs Landscape Analysis

    • 14.1 Switzerland Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    15. Turkey Peptic Ulcer Drugs Landscape Analysis

    • 15.1 Turkey Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Peptic Ulcer Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Peptic Ulcer Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Peptic Ulcer Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Peptic Ulcer Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Peptic Ulcer Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Peptic Ulcer Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Peptic Ulcer Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Peptic Ulcer Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Peptic Ulcer Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Peptic Ulcer Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Peptic Ulcer Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 AstraZeneca plc

      • 19.1.1 AstraZeneca plc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Takeda Pharmaceutical Co. Ltd.

      • 19.2.1 Takeda Pharmaceutical Co. Ltd. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Dr Reddy's Laboratories

      • 19.3.1 Dr Reddy's Laboratories Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Pfizer

      • 19.4.1 Pfizer Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Pozen

      • 19.5.1 Pozen Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Daiichi Sankyo

      • 19.6.1 Daiichi Sankyo Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Takeda Pharmaceutical Co Ltd

      • 19.7.1 Takeda Pharmaceutical Co Ltd Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Taiho Pharmaceutical

      • 19.8.1 Taiho Pharmaceutical Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Eumedica

      • 19.9.1 Eumedica Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Eisai Co Ltd

      • 19.10.1 Eisai Co Ltd Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Ferring Pharmaceuticals

      • 19.11.1 Ferring Pharmaceuticals Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Daewoong Pharmaceutical Co Ltd

      • 19.12.1 Daewoong Pharmaceutical Co Ltd Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Dr. Reddy's Laboratories

      • 19.13.1 Dr. Reddy's Laboratories Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 PharmaKing

      • 19.14.1 PharmaKing Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Johnson and Johnson

      • 19.15.1 Johnson and Johnson Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Otsuka Holdings

      • 19.16.1 Otsuka Holdings Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Eisai Co. Ltd.

      • 19.17.1 Eisai Co. Ltd. Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Horizon Pharma

      • 19.18.1 Horizon Pharma Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Daewoong Pharmaceutical Co. Ltd.

      • 19.19.1 Daewoong Pharmaceutical Co. Ltd. Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    The List of Tables and Figures (Totals 82 Figures and 155 Tables)

    • Figure Product Picture

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of Proton Pump Inhibitors (PPIs) from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of Potassium-Competitive Acid Blockers from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of Antacids from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of H2-antagonists from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of Antibiotics from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of Ulcer Protective Drugs from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of Private Clinics from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of Drug Stores from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Europe Peptic Ulcer Drugs Market Size and Growth Rate of E-Commerce from 2014 to 2026

    • Figure Germany Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Peptic Ulcer Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Peptic Ulcer Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Peptic Ulcer Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Peptic Ulcer Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Peptic Ulcer Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Proton Pump Inhibitors (PPIs)

    • Figure Market Size and Growth Rate of Potassium-Competitive Acid Blockers

    • Figure Market Size and Growth Rate of Antacids

    • Figure Market Size and Growth Rate of H2-antagonists

    • Figure Market Size and Growth Rate of Antibiotics

    • Figure Market Size and Growth Rate of Ulcer Protective Drugs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Peptic Ulcer Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Peptic Ulcer Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Private Clinics

    • Figure Market Size and Growth Rate of Drug Stores

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of E-Commerce

    • Table Europe Peptic Ulcer Drugs Production by Major Regions

    • Table Europe Peptic Ulcer Drugs Production Share by Major Regions

    • Figure Europe Peptic Ulcer Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Peptic Ulcer Drugs Consumption by Major Regions

    • Table Europe Peptic Ulcer Drugs Consumption Share by Major Regions

    • Table Germany Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table UK Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table France Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Peptic Ulcer Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Peptic Ulcer Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Peptic Ulcer Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Peptic Ulcer Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Germany Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table UK Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table France Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table France Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table France Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Italy Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Spain Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Poland Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Russia Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Peptic Ulcer Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Peptic Ulcer Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Peptic Ulcer Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Peptic Ulcer Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of AstraZeneca plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc

    • Figure Sales and Growth Rate Analysis of AstraZeneca plc

    • Figure Revenue and Market Share Analysis of AstraZeneca plc

    • Table Product and Service Introduction of AstraZeneca plc

    • Table Company Profile and Development Status of Takeda Pharmaceutical Co. Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Co. Ltd.

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Co. Ltd.

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Co. Ltd.

    • Table Product and Service Introduction of Takeda Pharmaceutical Co. Ltd.

    • Table Company Profile and Development Status of Dr Reddy's Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories

    • Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories

    • Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories

    • Table Product and Service Introduction of Dr Reddy's Laboratories

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Pozen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pozen

    • Figure Sales and Growth Rate Analysis of Pozen

    • Figure Revenue and Market Share Analysis of Pozen

    • Table Product and Service Introduction of Pozen

    • Table Company Profile and Development Status of Daiichi Sankyo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Product and Service Introduction of Daiichi Sankyo

    • Table Company Profile and Development Status of Takeda Pharmaceutical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Co Ltd

    • Table Product and Service Introduction of Takeda Pharmaceutical Co Ltd

    • Table Company Profile and Development Status of Taiho Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taiho Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Taiho Pharmaceutical

    • Figure Revenue and Market Share Analysis of Taiho Pharmaceutical

    • Table Product and Service Introduction of Taiho Pharmaceutical

    • Table Company Profile and Development Status of Eumedica

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eumedica

    • Figure Sales and Growth Rate Analysis of Eumedica

    • Figure Revenue and Market Share Analysis of Eumedica

    • Table Product and Service Introduction of Eumedica

    • Table Company Profile and Development Status of Eisai Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co Ltd

    • Figure Sales and Growth Rate Analysis of Eisai Co Ltd

    • Figure Revenue and Market Share Analysis of Eisai Co Ltd

    • Table Product and Service Introduction of Eisai Co Ltd

    • Table Company Profile and Development Status of Ferring Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ferring Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ferring Pharmaceuticals

    • Table Product and Service Introduction of Ferring Pharmaceuticals

    • Table Company Profile and Development Status of Daewoong Pharmaceutical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong Pharmaceutical Co Ltd

    • Figure Sales and Growth Rate Analysis of Daewoong Pharmaceutical Co Ltd

    • Figure Revenue and Market Share Analysis of Daewoong Pharmaceutical Co Ltd

    • Table Product and Service Introduction of Daewoong Pharmaceutical Co Ltd

    • Table Company Profile and Development Status of Dr. Reddy's Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr. Reddy's Laboratories

    • Figure Sales and Growth Rate Analysis of Dr. Reddy's Laboratories

    • Figure Revenue and Market Share Analysis of Dr. Reddy's Laboratories

    • Table Product and Service Introduction of Dr. Reddy's Laboratories

    • Table Company Profile and Development Status of PharmaKing

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PharmaKing

    • Figure Sales and Growth Rate Analysis of PharmaKing

    • Figure Revenue and Market Share Analysis of PharmaKing

    • Table Product and Service Introduction of PharmaKing

    • Table Company Profile and Development Status of Johnson and Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson and Johnson

    • Figure Sales and Growth Rate Analysis of Johnson and Johnson

    • Figure Revenue and Market Share Analysis of Johnson and Johnson

    • Table Product and Service Introduction of Johnson and Johnson

    • Table Company Profile and Development Status of Otsuka Holdings

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka Holdings

    • Figure Sales and Growth Rate Analysis of Otsuka Holdings

    • Figure Revenue and Market Share Analysis of Otsuka Holdings

    • Table Product and Service Introduction of Otsuka Holdings

    • Table Company Profile and Development Status of Eisai Co. Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co. Ltd.

    • Figure Sales and Growth Rate Analysis of Eisai Co. Ltd.

    • Figure Revenue and Market Share Analysis of Eisai Co. Ltd.

    • Table Product and Service Introduction of Eisai Co. Ltd.

    • Table Company Profile and Development Status of Horizon Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Horizon Pharma

    • Figure Sales and Growth Rate Analysis of Horizon Pharma

    • Figure Revenue and Market Share Analysis of Horizon Pharma

    • Table Product and Service Introduction of Horizon Pharma

    • Table Company Profile and Development Status of Daewoong Pharmaceutical Co. Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong Pharmaceutical Co. Ltd.

    • Figure Sales and Growth Rate Analysis of Daewoong Pharmaceutical Co. Ltd.

    • Figure Revenue and Market Share Analysis of Daewoong Pharmaceutical Co. Ltd.

    • Table Product and Service Introduction of Daewoong Pharmaceutical Co. Ltd.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.